LLY

1,029.45

+2.17%↑

JNJ

194.79

+0.15%↑

ABBV

238.96

+3.22%↑

UNH

336.18

-1.31%↓

AZN

89.15

+0.84%↑

LLY

1,029.45

+2.17%↑

JNJ

194.79

+0.15%↑

ABBV

238.96

+3.22%↑

UNH

336.18

-1.31%↓

AZN

89.15

+0.84%↑

LLY

1,029.45

+2.17%↑

JNJ

194.79

+0.15%↑

ABBV

238.96

+3.22%↑

UNH

336.18

-1.31%↓

AZN

89.15

+0.84%↑

LLY

1,029.45

+2.17%↑

JNJ

194.79

+0.15%↑

ABBV

238.96

+3.22%↑

UNH

336.18

-1.31%↓

AZN

89.15

+0.84%↑

LLY

1,029.45

+2.17%↑

JNJ

194.79

+0.15%↑

ABBV

238.96

+3.22%↑

UNH

336.18

-1.31%↓

AZN

89.15

+0.84%↑

Search

CareDx Inc

Abierto

SectorSanidad

16.06 -1.77

Resumen

Variación precio

24h

Actual

Mínimo

15.9

Máximo

16.38

Métricas clave

By Trading Economics

Ingresos

10M

1.7M

Ventas

13M

100M

P/B

Media del Sector

13.047

105.69

Margen de beneficios

1.674

Empleados

644

EBITDA

11M

6.8M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+31.11% upside

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

73M

859M

Apertura anterior

17.83

Cierre anterior

16.06

Noticias sobre sentimiento de mercado

By Acuity

40%

60%

149 / 374 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Neutral Evidence

CareDx Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

12 nov 2025, 21:55 UTC

Ganancias

Xero Beats 1st Half Profit Expectations Despite Melio Margin Hit

12 nov 2025, 21:34 UTC

Ganancias

Cisco Systems Boosts Fiscal Year Outlook as 1Q Profit, Revenue Rise

12 nov 2025, 23:44 UTC

Charlas de Mercado

Nikkei May Trade in Range Amid Caution Over U.S. Econ -- Market Talk

12 nov 2025, 23:38 UTC

Charlas de Mercado

Gold Steady Ahead of Expected End to U.S. Government Shutdown -- Market Talk

12 nov 2025, 23:13 UTC

Ganancias

Samsung Fire & Marine Insurance 3Q Net Profit Largely Met FactSet-Compiled Consensus

12 nov 2025, 23:13 UTC

Ganancias

Samsung Fire & Marine Insurance 3Q Net KRW538.50B Vs. Net KRW554.56B >000810.SE

12 nov 2025, 23:13 UTC

Ganancias

Samsung Fire & Marine Insurance 3Q Oper Pft KRW664.06B Vs. Pft KRW717.46B >000810.SE

12 nov 2025, 23:13 UTC

Ganancias

Samsung Fire & Marine Insurance 3Q Rev KRW5.732T Vs. KRW5.326T >000810.SE

12 nov 2025, 22:30 UTC

Charlas de Mercado
Ganancias

Firefly Aerospace Sets Plan for Next Launch After Explosion -- Market Talk

12 nov 2025, 22:18 UTC

Ganancias

Cisco Systems Boosts Outlook on AI-Driven Demand -- Update

12 nov 2025, 22:12 UTC

Charlas de Mercado

Bank of Canada Rate Hikes Could Start in 2H 2026 -- Market Talk

12 nov 2025, 22:05 UTC

Ganancias

Pan American Silver: Campbell Succeeded Steve Busby >PAAS

12 nov 2025, 22:04 UTC

Ganancias

Pan American Silver Named Scott Campbell as Operating Chief on Oct. 20

12 nov 2025, 22:04 UTC

Ganancias

Pan American Silver 3Q Adj EPS 48c >PAAS

12 nov 2025, 22:04 UTC

Ganancias

Pan American Silver 3Q Rev $884.4M >PAAS

12 nov 2025, 22:04 UTC

Ganancias

Pan American Silver 3Q EPS 45c >PAAS

12 nov 2025, 22:03 UTC

Ganancias

Manulife Financial: 3Q Book Value Per Common Shr C$26.07 >MFC.T

12 nov 2025, 22:02 UTC

Ganancias

Manulife Financial 3Q Net C$1.8B >MFC

12 nov 2025, 22:02 UTC

Ganancias

Manulife Financial 3Q Adj EPS C$1.16 >MFC

12 nov 2025, 22:02 UTC

Ganancias

Manulife Financial 3Q EPS C$1.02 >MFC

12 nov 2025, 21:53 UTC

Adquisiciones, fusiones, absorciones

BlueScope Steel: Sale Strengthens Focus on Own Growth Investments

12 nov 2025, 21:53 UTC

Adquisiciones, fusiones, absorciones

BlueScope Steel Says Deal Subject to Indian Regulatory Approvals

12 nov 2025, 21:53 UTC

Adquisiciones, fusiones, absorciones

BlueScope Steel Estimates Net Profit After Tax on Sale of A$70 Million

12 nov 2025, 21:53 UTC

Adquisiciones, fusiones, absorciones

BlueScope Steel Expects Net Proceeds After Taxes, Fees of A$179 Million in 2H FY26

12 nov 2025, 21:52 UTC

Adquisiciones, fusiones, absorciones

BlueScope Steel: Tata BlueScope Steel JV a Provider of Coated, Painted Steel Products in India

12 nov 2025, 21:51 UTC

Adquisiciones, fusiones, absorciones

BlueScope Steel Agrees to Sell 50% Stake in Tata BlueScope Steel Joint Venture to Tata Steel

12 nov 2025, 21:50 UTC

Charlas de Mercado
Ganancias

Basic Materials Roundup: Market Talk

12 nov 2025, 21:49 UTC

Ganancias

Cisco Stock Climbs as Earnings Beat Expectations Amid Strong AI Demand -- Barrons.com

12 nov 2025, 21:48 UTC

Ganancias

If Investors Like Rocket Lab Stock, They Should Love Firefly Shares. -- Barrons.com

12 nov 2025, 21:40 UTC

Ganancias

Xero Beats 1H Profit Expectations Despite Melio Margin Hit

Comparación entre iguales

Cambio de precio

CareDx Inc previsión

Precio Objetivo

By TipRanks

31.11% repunte

Estimación a 12 Meses

Media 22 USD  31.11%

Máximo 22 USD

Mínimo 22 USD

De acuerdo con 5 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para CareDx Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

5 ratings

2

Comprar

3

Mantener

0

Vender

Puntuación técnica

By Trading Central

14.77 / 18.49Soporte y Resistencia

Corto Plazo

Neutral Evidence

Medio plazo

Strong Bearish Evidence

Largo Plazo

Weak Bearish Evidence

Sentimiento

By Acuity

149 / 374 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de CareDx Inc

CareDx, Inc. engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally. It also provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company offers Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Allocell, a surveillance solution that monitors the level of engraftment and persistence of allogeneic cells for patients who have received cell therapy transplants; and XynQAPI cloud-based transplant quality management software, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.
help-icon Live chat